| Literature DB >> 34527805 |
Motohide Tanaka1, Ryobun Yasuoka1, Tomoya Nagano1, Yasuhito Kotake1, Masahiro Maruyama1, Hiromi Yamamoto1, Yoshitaka Iwanaga1, Yutaka Hirano1, Gaku Nakazawa1, Takashi Kurita1.
Abstract
BACKGROUND: Transesophageal echocardiography (TEE) is currently the gold standard technique for diagnosing left atrial appendage (LAA) thrombi. Cardiac computed tomography (CT) has been expected to become an alternative method to TEE; however, a reliable quantitative evaluation method has not been established. METHODS ANDEntities:
Keywords: Algorithm; Cardiac computed tomography; Left atrial appendage; Persistent atrial fibrillation; Thrombus; Transesophageal echocardiography
Year: 2021 PMID: 34527805 PMCID: PMC8433278 DOI: 10.1016/j.ijcha.2021.100866
Source DB: PubMed Journal: Int J Cardiol Heart Vasc ISSN: 2352-9067
Fig. 1Representative examples of presence and absence of LAA thrombus as observed by TEE and CT. A thrombus was defined as a well-contoured homogeneous echogenic mass within the LAA cavity by TEE (upper row). The patient with an LAA thrombus had a lower LAA blood flow velocity than the patient without an LAA thrombus (middle row). Cardiac CT of patients with an LAA thrombus showed a contrast-enhanced defect in the distal part of the LAA (lower row). The HU density was evaluated in a horizontal section with maximum depiction of the LAA cavity. Eight distinct points were determined at one proximal and seven distal sites of the LAA (LAAp and LAAd1–7, respectively). CT indicates computed tomography; HU, Hounsfield unit; LAA, left atrial appendage; TEE, transesophageal echocardiogram.
Fig. 2Study’s enrollment. AF indicates atrial fibrillation; CT, computed tomography; LAA, left atrial appendage; TEE, transesophageal echocardiogram.
Patients' background data.
| All patients | Non-thrombus group | Thrombus group | ||
|---|---|---|---|---|
| n = 177 | n = 164 | n = 13 | P Value | |
| Age (SD) | 65 (10) | 64 (9) | 70 (10) | 0.03 |
| Sex, m/f | 132/45 | 122/42 | 10/3 | 0.83 |
| HT | 108 | 98 | 10 | 0.21 |
| DM | 45 | 38 | 7 | 0.02 |
| CHF | 30 | 27 | 3 | 0.56 |
| Stroke | 18 | 16 | 2 | 0.54 |
| CHADS2 (SD) | 1.4 (1.1) | 1.3 (1.1) | 2.2 (1.4) | <0.01 |
| CHA2DS2 - VASC (SD) | 2.3 (1.6) | 2.3 (1.6) | 3.2 (2.3) | 0.07 |
| EF, % (SD) | 61 (11) | 61 (11) | 61 (12) | 0.82 |
| LAD, mm (SD) | 45 (6) | 44 (6) | 47 (5) | 0.1 |
| Interval between CT and TEE, day (SD) | 20.6 (33.9) | 20.0(32.3) | 28.2(50.7) | 0.4 |
| Anticoagulation, warfarin/DOAC | 14/163 | 11/153 | 3/10 | 0.08 |
| CT exposure dose, mGy· cm (SD) | 2129.7 (467.1) | 2143.7 (463.6) | 1955.6 (495.2) | 0.15 |
| TEE | ||||
| Empty flow, cm/s (SD) | 25.8 (14.3) | 26.8 (14.4) | 14.2 (3.8) | <0.01 |
| Filling flow, cm/s (SD) | 31.4 (15.1) | 32.5 (15.1) | 18.1 (5.5) | <0.01 |
| SEC, 0/1/2 | 104/48/25 | 104/45/15 | 0/3/10 | <0.01 |
| HU density | ||||
| d1 (SD) | 363.4 (56.1) | 362.5 (55.7) | 374.2 (62.6) | 0.47 |
| d2 (SD) | 352.3 (59.0) | 351.7 (59.6) | 359.6 (52.3) | 0.64 |
| d3 (SD) | 331.8 (66.1) | 333.2 (66.3) | 313.6 (62.7) | 0.31 |
| d4 (SD) | 293.0 (79.1) | 299.7 (74.2) | 209.3 (94.1) | <0.01 |
| d5 (SD) | 249.8 (100.6) | 258.7 (94.9) | 137.6 (106.8) | <0.01 |
| d6 (SD) | 215.6 (110.5) | 226.7 (106.8) | 76.8 (37.2) | <0.01 |
| d7 (SD) | 182.2 (103.8) | 192.4 (100.9) | 54.3 (24.7) | <0.01 |
Data are presented as n or mean ± standard deviation (SD).
CHADS2 indicates congestive heart failure, hypertension, age (≥75), diabetes mellitus, previous stroke/transient ischemic attack; CHA2DS2-VASc, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65–74 years, sex category; CHF, congestive heart failure; CT, computerized tomography; DM, diabetes mellitus; DOAC, direct oral anticoagulant; EF, ejection fraction; HT, hypertension; HU, Hounsfield unit; LAD, left atrial dimension; SEC, spontaneous echo contrast; TEE, transesophageal echocardiography.
Fig. 3Distribution of HU ratio in thrombus group and non-thrombus group at d1–7, and ROC analysis. A: The mean HU ratio in the thrombus group [A1] was significantly lower from d4 − 7 than that in the non-thrombus group [A2] (t test, p < 0.01). B: The ROC analysis for the relationship between the HU ratio at d7 and thrombus formation showed excellent discrimination for thrombus formation (AUC: 0.90). AUC indicates area under the curve; HU ratio, Hounsfield unit density ratio; ROC, receiver operating characteristic.
Fig. 4Distribution of HU-SD at d7 and ROC analysis. A: The HU-SD at d7 was significantly lower in the thrombus group than in the non-thrombus group (t test, p < 0.01). B: The ROC curve, which was plotted with the HU-SD against the presence of an LAA thrombus, demonstrated that an HU-SD of 20.14 was the best cut-off value to discriminate an LAA thrombus (AUC: 0.79). AUC indicates area under the curve; HU-SD, the standard deviation of Hounsfield unit density; LAA, left atrial appendage; ROC, receiver operating characteristic.
Fig. 5Logistic regression plot of the probability of thrombus formation between subgroups. As the HU ratio decreased, the probability of thrombus formation dramatically increased in subgroups with a low HU-SD. HU ratio indicates Hounsfield unit density ratio; HU-SD, the standard deviation of Hounsfield unit density.
Fig. 6Novel algorithm to evaluate presence of LAA thrombus. Among patients with an HU ratio of ≥0.26 (Category-Ia) or an HU ratio of <0.26 and an HU-SD of ≥26.94 (Category-Ib), no patients (n = 139) had a thrombus. Among the remaining patients, those with an HU-SD of <13.85 (n = 3) were diagnosed with a thrombus by TEE (Category-Ⅱ). Using this algorithm, it was possible to distinguish the presence or absence of an LAA thrombus in 142 out of 177 patients using CT alone. CT indicates computed tomography; HU ratio, Hounsfield unit density ratio; HU-SD, the standard deviation of Hounsfield unit density; LAA, left atrial appendage; TEE, transesophageal echocardiogram.
The diagnostic accuracy of our algorithm.
| Category-Ia : HU ratio at d7 ≥ 0.26 | |||||
|---|---|---|---|---|---|
| CT outcome | Diagnostic accuracy | ||||
| The remaining | Category-Ia | Sensitivity | 1.00 | ||
| Th group | 13 | 0 | Specificity | 0.77 | |
| Non-th group | 37 | 127 | Accuracy | 0.79 | |
| F value | 0.41 | ||||
| NPV | 1.00 | ||||
| Category-I : Category-Ia + Category-Ib | |||||
| CT outcome | Diagnostic accuracy | ||||
| Category-Ⅱ & III | Category-I | Sensitivity | 1.00 | ||
| Th group | 13 | 0 | Specificity | 0.85 | |
| Non-th group | 25 | 139 | Accuracy | 0.86 | |
| F value | 0.51 | ||||
| NPV | 1.00 | ||||
| Category-Ⅱ : HU ratio at d7 < 0.26 and HU-SD at d7 < 13.85 | |||||
| CT outcome | Diagnostic accuracy | ||||
| Category-Ⅱ | Category-Ⅰ & III | Sensitivity | 0.23 | ||
| Th group | 3 | 10 | Specificity | 1.00 | |
| Non-th group | 0 | 174 | Accuracy | 0.95 | |
| F value | 0.38 | ||||
| PPV | 1.00 | ||||
A: Confusion matrix for Category-Ia (HU ratio at d7 ≥ 0.26) and the remaining patients. There were no patient with thrombus group in this category. The diagnostic accuracy was 0.79.
B: Confusion matrix for Category-Ⅰ (Category-Ia + Category-Ib [ HU ratio at d7 < 0.26 and HU-SD at d7 ≥ 26.94]) and remaining patients (Category-Ⅱ and III). There were no patient with thrombus group in Category-Ⅰ. The diagnostic accuracy improved to 0.86.
C: Confusion matrix for Category-Ⅱ (HU ratio at d7 < 0.26 and HU-SD at d7 < 13.85) and remaining patients (Category-Ⅰ & III). There were no patients with non-thrombus group in Category-Ⅱ. The diagnostic accuracy improved to 0.95.
CT indicates computerized tomography; HU ratio, Hounsfield unit density ratio; HU-SD, the standard deviation of Hounsfield unit density; Non-th, non-thrombus; NPV, negative predictive value; Th, thrombus; PPV, positive predictive value.